Not currently recruiting at UCSD
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Summary
- Eligibility
- for people ages 6-17 (full criteria)
- Location
- at San Diego, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Dawn Eichenfield
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSD
- Dawn Eichenfield
Assistant Clinical Professor, Dermatology, Vc-health Sciences-schools. Authored (or co-authored) 25 research publications
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Eli Lilly and Company
- Links
- A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
- ID
- NCT05723198
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 595 study participants
- Last Updated